KNOWLEDGE & EXPERTISE
OncoLab brings together cutting-edge innovations with leading scientific expertise to take on one of the world’s most challenging diseases - cancer.
The OncoLab team combines profound knowledge and expertise in tumour biology, oncology and international research projects. Besides the high scientific quality, the CEO of OncoLab has long-term experience in managing and operating diagnostics enterprises as well as in developing and marketing diagnostic tests.
Robert Zeillinger, Dr. phil.
Founder, CEO and CSO of OncoLab Diagnostics. Robert Zeillinger has been active for more than 35 years in both academic and industrial research and development. He has extensive experience in successfully managing in-vitro diagnostic organisations and developing and commercialising diagnostic tests. His distinguished entrepreneurial ability is complemented by his proven ability to lead interdisciplinary and multinational teams.
Robert Zeillinger is also a renowned scientist. He is a Professor of Tumour Biology at the Medical University of Vienna, Austria, in a tenured position. He is author and co-author of more than 260 scientific publications and inventor of several granted patents.
Monika Rosenauer is the second managing director of the company. She possesses many years of experience in the bioprocess area and has worked for the biggest global players in this market.
She has a deep market knowledge and is an expert for global sourcing, supply chain management, change management and organizational development as well as in product and innovation management.
In other words, she is a specialist in translation of know how into everyday practice in order to strengthen your global performance.
Jana Groß, Dr. rer. nat.
Oncolab's Specialist for Regulatory Affairs and Product Quality. Jana Groß studied Chemistry and obtained her Master's degree from the University of Leipzig, Germany. She holds a Ph.D. in Organic Chemistry from the Graz University of Technology. She also has extensive experience in the processes of pharmaceutical industry: development, registration, quality control and management.
Esther Weiß, Dr. rer. nat.
Research Specialist at OncoLab. Esther Weiß studied Biology and obtained her Master’s degree from the Julius-Maximilians-University in Würzburg, Germany.
She performed her dissertation in the field of Immunology & Infection at the University Hospital in Würzburg, Germany.
At OncoLab she is responsible for test development under ISO 9001:2015 and ISO 13485:2016 and product quality management.
Eva Welsch, Dipl.-Ing.
R&D Specialist. Eva Welsch has a Master's degree in Biotechology from the University for Natural Resources and Life Sciences (BOKU) in Vienna and is registered for the Ph.D. program at the Medical University of Vienna, Austria. Since September 2019 she is part of the OncoLab R&D team and engaged in the development of new diagnostic products.
Christa Zeillinger, Dr. phil.
Production Specialist. Christa Zeillinger obtained her Doctor's degree in Biology from the University of Vienna, Austria. She has longstanding experience in diagnostic test kit production and quality control and assurance. Currently, she is also in charge of bookkeeping at OncoLab Diagnostics GmbH.
Cornelia Rella, Dipl.-Ing. (FH)
Expert in Quality management at OncoLab. She holds a Master’s degree in Medical and Pharmaceutical Biotechnology from the University of Applied Sciences FH Krems, Austria. Cornelia Rella has extensive experience in quality management.
Klara Bader, B.Sc.
R&D and Production Specialist. Klara Bader has a Bachelor's degree in bioengineering from the FH Campus Vienna - University of Applied Sciences.
Kamilla Malinowska-Ozdowy, Ph.D.
R&D Specialist. Kamilla Malinowska-Ozdowy has obtained her Doctor's degree from the Medical University of Innsbruck, Austria and has worked as a postdoctoral fellow in renowned Universities in Germany, Switzerland, Austria and the Czech Republic. At OncoLab she is engaged in test development and improvement.
Gabriel Wagner, Ph.D.
R&D Manager of OncoLab. Gabriel Wagner is an experienced molecular biologist. He has a Master's degree in Molecular Biology from the University of Vienna and obtained his Doctor's degree from the Medical University of Vienna, Austria. At OncoLab he is responsible for diagnostic test development under ISO 9001 and ISO 13485 and product quality management.
Martin Svoboda, Ph.D.
R&D and Production Manager of OncoLab. Martin Svoboda is an experienced molecular biologist. He has a Master's degree in Molecular Biology from the University of Vienna and obtained his Doctor's degree from the Medical University of Vienna, Austria. At OncoLab he is responsible for test development under ISO 9001:2015 and ISO 13485:2016 and product quality management.
Brajakta Bjad, Ph.D.
R&D Specialist. Brajad Bajad studied Biotechnology at the University of Pune, India, and graduated with a Master’s degree. She holds a Ph.D. in molecular biology from the University of Vienna, Austria. She is experienced in a variety of molecular biology techniques and next generation sequencing techniques. At OncoLab she is responsible the development of PCR-based test.
Nicole Heinzl, M.S.
R&D Specialist. Nicole Heinzl studied Molecular Biology and obtained her Master's degree from the University of Vienna, Austria. She is currently enrolled in the Ph.D. program "Malignant Diseases" at the Medical University of Vienna. At OncoLab she is responsible for the development of new diagnostic tests for the detection of tumor suppressor protein aggregates.
Katharina Stasny, BMA
R&D and production specialst.